Lim Bryant David

Avg. Two Year Performance

40% Avg. Purchase Return
18% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(4%)(2%)(6%)(50%)40%
Purchase Success Rate0 of 10 of 10 of 10 of 11 of 1
Average Sale Return(7%)37%(< 1%)(13%)0%
Sale Success Rate2 of 32 of 30 of 30 of 30 of 3
Other » Other

CLO, Interim CFO, Corp Sec.:

Holdings: 2.4K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

SVP and General Counsel:

Holdings: 309.69K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--